Clinical Trial Update: Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating lenvatinib in combination with everolimus in unresectable advanced or metastatic renal cell carcinoma has completed with posted results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Everolimus (everolimus)
• Lenvatinib (lenvatinib)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Carcinoma, Renal Cell | Phase 1 | Status: COMPLETED | Results posted: 2019-02-08